Browsing items tagged “Jim Lang | EVERSANA”

EVERSANA™ unveils EVERSANA CONSULTING, portfolio of consulting services to solve challenges across the life sciences sector

CHICAGO – February 6, 2020  – Fueled by the growing demand for seasoned consulting expertise, EVERSANA™, the leading independent provider of commercial services to the life sciences industry, today unveiled EVERSANA CONSULTING, the new name of its global consulting services focused on the pharmaceutical and biotechnology industries. EVERSANA CONSULTING is built to address challenges across […]

Evoke Pharma Enters Commercialization Agreement with EVERSANA for Gimoti™

EVERSANA to commercialize and distribute Gimoti in the U.S. EVERSANA to provide $5 million revolving credit facility upon FDA approval SOLANA BEACH, CA, and CHICAGO, IL. January 23, 2020 – Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, and EVERSANA™, an independent provider of global commercial services […]

EVERSANA™ launches EVERSANA ENGAGE, a full-solution marketing agency to reach patients, providers and payers across the care continuum

CHICAGO – January 7, 2020 – EVERSANA™, the leading independent provider of commercial services to the life sciences industry, today unveiled EVERSANA ENGAGE, the full-solution healthcare marketing agency uniquely designed to help pharmaceutical and biotechnology companies cohesively reach patients, providers and payers to enhance the patient experience and improve outcomes. EVERSANA ENGAGE combines EVERSANA’s market […]

EVERSANA™ announces an agreement to acquire Cornerstone Research Group; adds global HEOR capabilities to integrated commercial services platform

CHICAGO  – October 30, 2019  – EVERSANA™, the leading independent provider of commercial services to the life sciences industry, today announced an agreement to acquire Canada-based Cornerstone Research Group, Inc. Headquartered in Burlington, Ontario with an additional location in Sydney, Nova Scotia, Cornerstone Research Group is the leader in Health Economics and Outcomes Research (HEOR) […]

EVERSANA™ named a Great Place to Work by global workplace authority

CHICAGO – October 28, 2019 – EVERSANA™, the leading independent provider of commercial services to the life sciences industry, has been certified as a Great Place to Work® by the global authority in workplace culture. EVERSANA ranked in the top 15 percent of more than 6,000 organizations worldwide who have submitted for the coveted certification. […]

Cognoa and EVERSANA™ announce partnership to advance the commercialization standard for prescription digital medicines

PALO ALTO, Calif. And CHICAGO – September 10, 2019 – Cognoa, a company at the forefront of pediatric behavioral health, and EVERSANA™, the leading independent provider of global commercial services to the life science industry, today announced a partnership to advance the industry standard by which digital medicines will be ordered, dispensed, and covered by […]

EVERSANA™ opens offices in Singapore & Mumbai as Asia Pacific commercial business rapidly expands

CHICAGO – August 6, 2019 – EVERSANA™, the leading independent provider of global commercial services to the life science industry, today announced the rapid expansion of its Asia Pacific business with the addition of two new offices in Singapore and Mumbai. The announcement comes as the company appoints a regional leadership team which will be […]

Cryoport and EVERSANA Form Strategic Alliance to Accelerate Regenerative Medicine Supply Chain

IRVINE, California, July 11, 2019 – Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) and EVERSANA™ have announced a strategic alliance to further create a fully integrated regenerative medicine supply chain solution. The alliance will be designed to leverage EVERSANA’s position as the leading provider of commercial services addressing access, affordability and adherence challenges for cell and […]